18.03.2015 17:37:12
|
GLOBAL BIOENERGIES: Completion of the basic engineering phase of the Leuna Demo Plant
GLOBAL BIOENERGIES: Completion of the basic engineering phase of the Leuna Demo Plant
Leuna, March 18th, 2015 - Global Bioenergies and The Linde Group today announce the completion of the basic engineering phase of Global Bioenergies' demo plant.
In February 2014, Global Bioenergies entrusted the Engineering Division of technology company The Linde Group with the mission to deliver the basic engineering study upstream of the construction of its demonstration plant. Today, the two companies are glad to announce that this phase has now been completed successfully.
Markus Wolperdinger, Vice President Biotechnology Plants at Linde's Engineering Division said: "We are proud to deliver to Global Bioenergies a complete basic engineering package for its process to convert sugars into isobutene, a gaseous hydrocarbon. This one-of-a-kind demo plant will be an important milestone on the way to the commercialization of Global Bioenergies' innovative biotechnological processes".
Rick Bockrath, VP chemical engineering at Global Bioenergies, added: "We are now ready to move on to the next phase of the project, dedicated to the construction and exploitation of the demo plant."
The demo plant, expected to be installed in the Fraunhofer CBP building at the Leuna complex, is associated with a EUR 5.7m grant from the German Federal Ministry of Research (BMBF).
About GLOBAL BIOENERGIES
Global Bioenergies is one of the few companies worldwide, and the only one in Europe, that is developing a process to convert renewable resources into hydrocarbons through fermentation. The Company initially focused its efforts on the production of isobutene, one of the most important petrochemical building blocks that can be converted into fuels, plastics, organic glass and elastomers. Global Bioenergies continues to improve the yield of its process and recently announced success with first testing in its industrial pilot. The company also replicated its achievement to propylene and butadiene two members of the gaseous olefins family, key molecules at the heart of petrochemical industry. Global Bioenergies is listed on Alternext, Euronext Paris (FR0011052257 - ALGBE).
About THE LINDE GROUP
In the 2013 financial year, The Linde Group generated revenue of EUR 16.655 bn, making it the largest gases and engineering company in the world with approximately 63,500 employees working in more than 100 countries worldwide. The strategy of The Linde Group is geared towards long-term profitable growth and focuses on the expansion of its international business with forward-looking products and services. Linde acts responsibly towards its shareholders, business partners, employees, society and the environment - in every one of its business areas, regions and locations across the globe. The company is committed to technologies and products that unite the goals of customer value and sustainable development.
Should you like to be kept informed, subscribe to our news feed on
www.global-bioenergies.com
Follow us on Twitter: @GlobalBioenergi
Contact
GLOBAL BIOENERGIES
Jean-Baptiste Barbaroux Head of Corporate Development Tel : + 33 (0) 1 64 98 20 50 Email : jean-baptiste.barbaroux@global-bioenergies.com |
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: GLOBAL BIOENERGIES via Globenewswire

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Global Bioenergiesmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Global Bioenergiesmehr Analysen
Aktien in diesem Artikel
Global Bioenergies | 1,36 | -3,55% |
|